Patents by Inventor Pingwei Zhao

Pingwei Zhao has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PYRAZOLYLBENZENE-1,3-DIOLS FOR DISEASES ASSOCIATED WITH G PROTEIN-COUPLED RECEPTOR 18 AND IN COMBINATION WITH TRANSIENT RECEPTOR POTENTIAL VANILLOID 1
    Publication number: 20210323927
    Abstract: The present invention relates to pyrazolylbenzene-1,3-diols as cannabidiol derivatives, its use for the manufacture of a medicament, and more particularly, to the use of this medicament for the treatment and/or prevention of a disorder associated with the GPR18 and/or TRPV1 receptors and the use of these compounds for pharmacological assays related to GPR18 and/or TRPV1.
    Type: Application
    Filed: April 16, 2021
    Publication date: October 21, 2021
    Inventors: Mary Ellen Abood, Eugen Brailoiu, Luciana Magalhaes Leo, Pingwei Zhao
  • Treatment of disorders associated with G protein-coupled receptor 35 (GPR35)
    Patent number: 9622995
    Abstract: Compounds are provided having agonistic activity against G protein-coupled receptor 35 (GPR35). The compounds are useful for providing antinociception, providing neuroprotection in case of stroke or ischemia, or treating gastric inflammation.
    Type: Grant
    Filed: May 13, 2015
    Date of Patent: April 18, 2017
    Assignees: TEMPLE UNIVERSITY—Of The Commonwealth System of Higher Education, DUKE UNIVERSITY, RESEARCH TRIANGLE INSTITUTE
    Inventors: Mary E. Abood, Pingwei Zhao, Lawrence S. Barak, Herbert H. Seltzman
  • TREATMENT OF DISORDERS ASSOCIATED WITH G PROTEIN-COUPLED RECEPTOR 35 (GPR35)
    Publication number: 20150265561
    Abstract: Compounds are provided having agonistic activity against G protein-coupled receptor 35 (GPR35). The compounds are useful for providing antinociception, providing neuroprotection in case of stroke or ischemia, or treating gastric inflammation.
    Type: Application
    Filed: May 13, 2015
    Publication date: September 24, 2015
    Inventors: Mary E. Abood, Pingwei Zhao, Lawrence S. Barak, Herbert H. Seltzman
  • Treatment of disorders associated with G protein-coupled receptor 35 (GPR35)
    Patent number: 9040583
    Abstract: Compounds are provided having agonistic activity against G protein-coupled receptor 35 (GPR35). The compounds are useful for providing antinociception, providing neuroprotection in case of stroke or ischemia, or treating gastric inflammation.
    Type: Grant
    Filed: July 14, 2010
    Date of Patent: May 26, 2015
    Assignees: Temple University-Of the Commonwealth System of Higher Education, Duke University, Research Triangle Institute
    Inventors: Mary E. Abood, Pingwei Zhao, Lawrence S. Barak, Herbert H. Seltzman
  • TREATMENT OF DISORDERS ASSOCIATED WITH G PROTEIN-COUPLED RECEPTOR 35 (GPR35)
    Publication number: 20120122987
    Abstract: Compounds are provided having agonistic activity against G protein-coupled receptor 35 (GPR35). The compounds are useful for providing antinociception, providing neuroprotection in case of stroke or ischemia, or treating gastric inflammation.
    Type: Application
    Filed: July 14, 2010
    Publication date: May 17, 2012
    Applicants: Temple University of the Commonwealth System of Higher Education, Research Triangle Institute, Duke University
    Inventors: Mary E. Abood, Pingwei Zhao, Lawrence S. Barak, Herbert H. Seltzman